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We used placental tissue to compare the imprinted gene expression of IGF2, H19, KCNQ1OT1, and CDKN1C of singletons
conceived via assisted reproduction technology (ART) with that of spontaneously conceived (SC) singletons. Of 989 singletons
examined (ART n = 65; SC n = 924), neonatal weight was signiﬁcantly lower (P<. 001) in the ART group than in the SC group,
but placental weight showed no signiﬁcant diﬀerence. Gene expression analyzed by real-time PCR was similar for both groups
with appropriate-for-date (AFD) birth weight. H19 expression was suppressed in fetal growth retardation (FGR) cases in the ART
and SC groups compared with AFD cases (P<. 02 and P<. 05, resp.). In contrast, CDKN1C expression was suppressed in FGR
cases in the ART group (P<. 01), while KCNQ1OT1 expression was hyperexpressed in FGR cases in the SC group (P<. 05). As
imprinted gene expression patterns diﬀered between the ART and SC groups, we speculate that ART modiﬁes epigenetic status
even though the possibilities always exist.
1.Introduction
Assisted reproduction technology (ART) is associated with
epigenetic alterations [1–3] that can aﬀect fetal growth in
animals and humans and usually results from imprinting.
Followup studies of ART-conceived children have shown
that ART does not increase the incidence of congenital
abnormalities [4–10]; however, it increases the incidence of
epigenetic disorder diseases, such as Beckwith-Wiedemann
Syndrome (BWS), Angelman Syndrome (AS), and Russell-
Silver Syndrome (RSS) [11–17].
In BWS [MIM 130650] and RSS [MIM 180860], abnor-
mal fetal growth is a major phenomenon, and abnormal
prenatal development has been associated with the epigenet-
ics of some imprinted genes. Reduced birth weight, which
is occasionally observed in infants conceived by ART, is an
importantconsiderationasitisassociatedwithadultdiseases
such as insulin insensitivity, polycystic ovary syndrome, and
cardiovascular diseases [18–20]. Therefore, normal prenatal
development may be very important not only for childhood
health but also for long-term health. Here, we used human
placental tissue to compare the imprinted gene expression
of IGF2, H19, KCNQ1OT1, and CDKN1C genes known to
be associated with fetal growth, in ART-conceived singletons
with that in spontaneously conceived (SC) singletons.
2.MaterialsandMethods
A total of 1302 singletons delivered at our center from June
2005toMarch2007wereenrolledinthisstudy.Ofthese1302
potential subjects, 313 were excluded due to complications.
A total of 860 infants had appropriate-for-date (AFD) birth
weight (2500g ≤ AFD birth weight < 3500g), 64 cases
exhibiting fetal growth retardation (FGR) had a birth weight
of <2500g, and 65 cases had a birth weight of ≥3500g. Thus,
989 subjects (ART n = 65; SC n = 924) were assessed with
3 idiopathic FGR cases in the ART group and 61 in the SC
group (Table 1).
For the gene expression study, placental tissue was
collected from 297 cases after receiving informed consent2 Obstetrics and Gynecology International
Table 1: Subject characteristics.
ART (n)S C ( n)T o t a l ( n)
AFD (2500g ≤, <3500g) 62 798 860
FGR (≤ 2500g) 3 61 64
OG (≥3500g) — 65 65
Total 65 924 989
n: number of cases, AFD: appropriate-for-date, FGR: fetal growth retar-
dation, OG: over growth, ART: assisted reproductive technology, and SC:
spontaneous conception.
Table 2: Imprinted gene expression analysis in placental tissue
samples.
ART (n)S C ( n)T o t a l ( n)
AFD (≥2500g, <3500g) 45 173 218
FGR (≤2500g) 3 51 54
OG (≥3500g) — 25 25
Total 48 249 297
n: number of cases, AFD: appropriate-for-date, FGR: fetal growth retar-
dation, OG: over growth, ART: assisted reproductive technology, and SC:
spontaneous conception.
Table 3: Birth weight and placenta weight.
Weight (g)
n Neonate Placenta
ART 65 2905.1 ± 459.0∗ 589.3 ± 152.6
SC 924 3607.9 ± 589.9∗ 613.0 ± 142.5
∗P<. 001. n: number of cases, ART: assisted reproductive technology, and
SC: spontaneous conception.
under the IRB protocol of our center for genetic analysis
(Table 2). Total RNA was extracted from the fetal placenta,
and reverse transcription was performed. Gene expressions
of IGF2, H19, KCNQ1OT1, and CDKN1C were analyzed
by real-time PCR with GAPDH serving as the endogenous
control.
3. Results andDiscussion
The mean birth weight was signiﬁcantly lower (P<.001) in
the ART group (2905.1 ± 459.0g) than in the SC group
(3607.9 ± 589.9g). The mean placental weight, however,
showed no signiﬁcant diﬀerence (ART = 689.3 ± 152.6g;
SC = 613.0 ± 142.5g) (Table 3). Gene expression patterns
in the AFD birth weight cases were similar in both the
ART and SC groups (Figure 1). H19 expression was reduced
in FGR cases both in the ART and SC groups compared
with the AFD cases (P <.02 and P<.05, resp.) (Figure 2).
Conversely, H19 expression was signiﬁcantly enhanced in SC
c a s e sw i t hab i r t hw e i g h to f≥3500g (P<.01) (Figure 3).
On the other hand, CDKN1C expression was reduced in
ART cases with FGR (P<.01), and KCNQ1OT1 appeared
to be hyperexpressed in SC cases with FGR (P< .05)
(Figure 2). The expression of other genes examined showed
no diﬀerence from the control.
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Figure 1: Gene expression of placental tissue. ART versus SC in
AFD birth weight cases. ART: assisted reproductive technology.
SC: spontaneous conception. AFD: appropriate-for-date. Results of
gene expression analysis compared with the endogenous control
GAPDH. In AFD birth weight cases, gene expression patterns were
similar in both the ART and SC groups.
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Figure 2: Gene expression of placental tissue. ART versus SC in
FGR cases. There were no diﬀerences in the gene expression of
IGF2; however, H19 expression was signiﬁcantly reduced in FGR
cases both in the ART and SC groups compared with the AFD birth
weight cases (P<.02 and P<.05, resp.). Conversely, KCNQ1OT1
was hyperexpressed in FGR cases in the SC group (P<.05), while
CDKN1C expression was reduced in FGR cases in the ART group
(P<.01).
The results demonstrated that birth weight was signiﬁ-
cantly lower in the ART group than in the SC group, which is
in agreement with the results of other studies [21–23]. Some
followup studies of ART-conceived children suggest that low
b i r t hw e i g h ti sd u et om u l t i p l ep r e g n a n c i e s .H o w e v e r ,e v e n
in singleton cases, low birth weight has been observed in
infants conceived by ART. For cases conceived using fresh
embryo replacement, birth weight was comparably lower
than that for cases conceived using cryopreserved embryos
[24, 25]. Although we did not separate cases conceived with
fresh embryos and cryopreserved embryos, many cases in
this study were conceived by fresh embryo replacement.
On the other hand, placental weight showed no signiﬁcant
diﬀerence between the ART and SC groups. In other studies,
however, placental thickness was signiﬁcantly larger in ARTObstetrics and Gynecology International 3
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Figure 3:Geneexpressioninplacentaltissue.FGRandbirthweight
≥3500g cases in the SC group. H19 expression was signiﬁcantly
reduced in FGR cases, but signiﬁcantly enhanced in cases with a
birth weight of ≥3500g (P<.01).
cases than in SC cases, but there were no diﬀerences in
morphological or histopathological features of the placenta
b e t w e e nb o t hg r o u p s[ 26]. There were no diﬀerences in the
gene expression patterns in the AFD cases between the ART
and SC groups. However, the expression of H19, a paternally
methylated imprinted gene, was reduced in FGR cases in
both the ART and SC groups. As maternally expressed genes
such as H19 enhance fetal development, the hypoexpression
of H19 aﬀects fetal development. Here, we established
the relationship between the hypoexpression of H19 and
reducedfetalweight.Additionally,CDKN1C,anothermater-
nally expressed gene, exhibited reduced expression in FGR
cases conceived by ART. In contrast, the expression of
KCNQ1OT1, a paternally expressed gene with a comple-
mentary relationship to CDKN1C, was enhanced in FGR
cases conceived by natural conception. In this study, we
conﬁrmed diﬀerences in the expression of imprinted genes
in the placental tissue of infants conceived by ART. However,
even in the SC cases, epigenetic alteration has been observed.
The loss of imprinting on genes located on chromosome
11 is identiﬁed as a cause of poor fetal growth in humans
[27], which is also reﬂected in our study. We postulate
that ART could aﬀect the epigenetic characteristics of male
and female gametes or it can have an impact on early
embryogenesis. Additionally, ART could be associated with
an increased risk of genomic imprinting abnormalities as
epigenetic reprogramming occurs during gametogenesis or
immediately following fertilization [28–32].
4. Conclusions
Imprinted gene expression patterns of placental tissue in
FGR cases were altered compared with cases of normal fetal
growth. However, imprinted gene expression patterns of
placental tissue in ART cases were diﬀerent from those of SC
cases.Incaseswithabirthweightof≥3500g,geneexpression
diﬀered from cases with standard fetal growth. While we
recognizethepossibilityofchangesinepigeneticstatusinany
pregnancy, we speculate that epigenetic status is altered by
ART.AlthoughARThasbeenwidelyacceptedandsafetyper-
formed, epigenetics should remain an important factor for
evaluating the safe development of reproductive medicine, as
well as for considering the health of the next generation.
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